Markets:

Overview

News

Currencies

International

Treasuries

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

37.21 -0.14 (-0.37%)

Streaming Delayed Price Updated: 11:06 AM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mineralys Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market ↗

July 17, 2023

The global acute hospital care market was worth $3.2 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.62% from 2023 to 2030.

Via Benzinga

Where Mineralys Therapeutics Stands With Analysts ↗

May 16, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

Where Mineralys Therapeutics Stands With Analysts ↗

March 16, 2023

Via Benzinga

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying ↗

February 17, 2023

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 14, 2023

During Tuesday, 40 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 13, 2023

On Monday, 42 companies hit new 52-week lows.

Via Benzinga

There's a Lot to Love About Mineralys' Valentine's Day IPO

February 13, 2023

MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million

Via MarketBeat

Topics Initial Public Offering

Opening Day: Hesai Scores Biggest U.S. Debut By Chinese Company Since Didi ↗

February 11, 2023

Shares of Hesai, a developer of sensor technologies used in self-driving cars, jumped as much as 29% in its first trading day, making the listing the largest by a Chinese issuer in the U.S. since Didi...

Via Talk Markets

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

All News about Mineralys Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today